An Examination of Cognitive Fatigue Using Functional Neuroimaging
Status: Recruiting
Location: See location...
Intervention Type: Drug
Study Type: Observational
SUMMARY
The purpose of this research study is to investigate the effectiveness of MS Disease modifying medications on cognitive fatigue in persons with relapsing remitting multiple sclerosis (RRMS). Cognitive fatigue is the kind of fatigue that occurs after intense mental concentration as after a session of problem solving.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 64
Healthy Volunteers: t
View:
• Age between 18-64.
• Relapsing remitting multiple sclerosis
• Been newly prescribed a new disease modifying medication for MS (either Zeposia or other high dose oral efficacy medication)
• or healthy volunteer who can speak English fluently.
Locations
United States
New Jersey
Kessler Foundation
RECRUITING
West Orange
Contact Information
Primary
Nancy Moore
nbmoore@kesslerfoundation.org
973-324-8450
Backup
Amanda PraSisto
aprasisto@kesslerfoundation.org
973-324-3507
Time Frame
Start Date: 2022-01-01
Estimated Completion Date: 2024-12
Participants
Target number of participants: 60
Treatments
MS Zeposia
Individuals with MS who will begin taking Zeposia as part of standard care.
MS High dose efficacy medication
Individuals with MS who will begin taking high dose efficacy oral medication as part of standard of care.
Healthy Control
Healthy controls, all of whom will be matched on age, education and gender to the MS groups.
Related Therapeutic Areas
Sponsors
Collaborators: St. Barnabas Medical Center, Hackensack Meridian Health, Celgene
Leads: Kessler Foundation